Skip to main content
ConductScienceScienceDex

Ravi Radhakrishnan

NIH Rank #8893
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8468324Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Pharmacology
  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$1.5M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#8,893
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ravi Radhakrishnan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Ravi Radhakrishnan as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA244660-05R01
    Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
    Yale University
    $643.7K
    award amount
  • 5U01CA250044-04U01
    A physical sciences approach to investigate the role of exosomes in metastatic progression
    University of Pennsylvania
    $639K
    award amount
  • 3U01CA250044-04S2U01
    A physical sciences approach to investigate the role of exosomes in metastatic progression
    University of Pennsylvania
    $112K
    award amount
  • 3U01CA250044-04S1U01
    A physical sciences approach to investigate the role of exosomes in metastatic progression
    University of Pennsylvania
    $77.4K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Ravi Radhakrishnan as a PI.

University of Pennsylvania
PA
$828.4K
3 grants
Yale University
CT
$643.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8893
  5. 2024
    R01 Grant Holder
  6. 2025
    $2M Cumulative Funding
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Ravi Radhakrishnan.

Valerie Marie Weaver
University of Pennsylvania
4
shared awards
Wei Guo
University of Pennsylvania
4
shared awards
Boris N Kholodenko
Yale University
1
shared award
Mark A Lemmon
Yale University
1
shared award
William S Hlavacek
Yale University
1
shared award

Explore further

Find collaborators for Ravi Radhakrishnan

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →